Charles G. Lineberry
Founder at Lineberry Research Associates LLC
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| John Didsbury | M | 68 |
T3D Therapeutics, Inc.
 T3D Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology T3D Therapeutics, Inc. engages in the development of its drug product candidate, T3D-959, to treat Alzheimer's disease. The company was founded in 2013 and is headquartered in Research Triangle Park, NC. | - |
| Cathy Frieden Lineberry | F | - |
Lineberry Research Associates LLC
 Lineberry Research Associates LLC Miscellaneous Commercial ServicesCommercial Services Lineberry Research Associates LLC operates as a contract research and consulting company, offers drug research, development, and marketing services to pharmaceutical and biotechnology companies. Its services include strategic consulting, clinical research and regulatory affairs, scientific writing and communications. The company was founded in July 1995 by Cathy Frieden Lineberry and is headquartered in Research Triangle Park, NC. | - |
| J. Barry Buzogany | M | - |
T3D Therapeutics, Inc.
T3D Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology T3D Therapeutics, Inc. engages in the development of its drug product candidate, T3D-959, to treat Alzheimer's disease. The company was founded in 2013 and is headquartered in Research Triangle Park, NC. | 11 years |
| John A. Golden | M | 79 |
T3D Therapeutics, Inc.
T3D Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology T3D Therapeutics, Inc. engages in the development of its drug product candidate, T3D-959, to treat Alzheimer's disease. The company was founded in 2013 and is headquartered in Research Triangle Park, NC. | - |
| Thomas G. Mendell | M | - |
T3D Therapeutics, Inc.
T3D Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology T3D Therapeutics, Inc. engages in the development of its drug product candidate, T3D-959, to treat Alzheimer's disease. The company was founded in 2013 and is headquartered in Research Triangle Park, NC. | 8 years |
| David B. Keim | M | - |
T3D Therapeutics, Inc.
T3D Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology T3D Therapeutics, Inc. engages in the development of its drug product candidate, T3D-959, to treat Alzheimer's disease. The company was founded in 2013 and is headquartered in Research Triangle Park, NC. | 5 years |
Connections Chart
Multi-company connection
Statistics
| Country | Connections | % of total |
|---|---|---|
| United States | 6 | 100.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Charles G. Lineberry
- Personal Network
